Technology

Shire's Actual 2020 Sales Could Be 'Way North' Of $10 Billion

Shire's (SHP.L) own deal-making capacity is likely to push the drugmaker's annual sales "way north" of the $10 billion it is currently forecasting for 2020 on the basis of the existing portfolio, its chief executive said on Monday.